2-(anilino)imidazolines and 2-(benzyl)imidazoline derivatives as h5-HT1D serotonin receptor ligands

被引:3
作者
Prisinzano, T
Dukat, M
Law, H
Slassi, A
MacLean, N
DeLannoy, I
Glennon, RA
机构
[1] Virginia Commonwealth Univ, Sch Pharm, Dept Med Chem, Richmond, VA 23298 USA
[2] NPS Pharmaceut, Mississauga, ON L4V 1V7, Canada
关键词
serotonin migraine;
D O I
10.1016/j.bmcl.2004.06.085
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
2-(Anilino)imidazolines were identified as novel human 5-HT1D receptor ligands, but offered no particular advantage over previously reported 2-(benzyl)imidazolines. Pharmacokinetic and functional data were obtained for selected 2-(benzyl)imidazoline derivatives. (C) 2004 Elsevier Ltd. All rights reserved.
引用
收藏
页码:4697 / 4699
页数:3
相关论文
共 14 条
[1]   Med-psych drug-drug interactions update - Triptans [J].
Armstrong, SC ;
Cozza, KL .
PSYCHOSOMATICS, 2002, 43 (06) :502-504
[2]  
BEELEY LJ, 1982, Patent No. 43659
[3]   Effect of naratriptan on myocardial blood flow and coronary vasodilator reserve in migraineurs [J].
Gnecchi-Ruscone, T ;
Bernard, X ;
Pierre, P ;
Anderson, D ;
Legg, N ;
Enahoro, H ;
Winter, PDO ;
Crisp, A ;
Melin, JA ;
Camici, PG .
NEUROLOGY, 2000, 55 (01) :95-99
[4]   Benzylimidazolines as h5-HT1B/1D serotonin receptor ligands:: A structure-affinity investigation [J].
Law, H ;
Dukat, M ;
Teitler, M ;
Lee, DKH ;
Mazzocco, L ;
Kamboj, R ;
Rampersad, V ;
Prisinzano, T ;
Glennon, RA .
JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (13) :2243-2251
[5]  
Millson D S, 2000, Expert Opin Pharmacother, V1, P391, DOI 10.1517/14656566.1.3.391
[6]  
Moskowitz M A, 1993, Neurology, V43, pS16
[7]   Hemodynamic and coronary effects of intravenous eletriptan, a 5HT1B/1D-receptor agonist [J].
Muir, DF ;
McCann, GP ;
Swan, L ;
Clark, AL ;
Hillis, WS .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1999, 66 (01) :85-90
[8]   Pharmacological treatments for acute migraine: quantitative systematic review [J].
Oldman, AD ;
Smith, LA ;
McQuay, HJ ;
Moore, RA .
PAIN, 2002, 97 (03) :247-257
[9]   Imidazoline-modified benzylimidazolines as h5-HT1D/1B serotonergic ligands [J].
Prisinzano, T ;
Law, H ;
Dukat, M ;
Slassi, A ;
MaClean, N ;
Demchyshyn, L ;
Glennon, RA .
BIOORGANIC & MEDICINAL CHEMISTRY, 2001, 9 (03) :613-619
[10]  
Prisinzano T, 2001, MED CHEM RES, V10, P309